Technical Analysis for RCKT - Rocket Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
D 40.91 -0.07% -0.03
RCKT closed down 0.07 percent on Friday, May 14, 2021, on approximately normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical RCKT trend table...

Date Alert Name Type % Chg
200 DMA Support Bullish 0.00%
Calm After Storm Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Multiple of Ten Bullish Other 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
200 DMA Support Bullish -0.07%
Calm After Storm Range Contraction -0.07%
Older End-of-Day Signals for RCKT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Rocket Pharmaceuticals, Inc. Description

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating pediatric diseases. It has clinical-stage lentiviral vector (LVV) programs under clinical testing to treat fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; and leukocyte adhesion deficiency-I, a genetic disorder that causes the immune system to malfunction It also has additional pre-clinical stage LVV programs include pyruvate kinase deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia; and infantile malignant osteopetrosis, a genetic disorder characterized by increased bone density and bone mass secondary to impaired bone resorption. In addition, the company has an adeno-associated virus program for Danon disease, a multi-organ lysosomal-associated disorder leading to early death due to heart failure. It has license agreements with Fred Hutchinson Cancer Research Center; Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Centro de Investigacion Biomedica En Red, and Fundacion Instituto de investigacion Sanitaria Fundacion Jimenez Diaz; CIEMAT and UCL Business PLC; The Regents of the University of California; and REGENXBIO Inc. The company also has a research and collaboration agreement with Lund University; and strategic collaboration agreement with Stanford University School of Medicine. Rocket Pharmaceuticals, Inc. is headquartered in New York, New York.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Immune System Bone Heart Failure Anemia Bone Marrow Red Blood Cell Blood Cells Genetic Disorder Cancer Research Rocket Petros Stanford University Danon Fanconi Anemia Pyruvate Kinase Deficiency

Is RCKT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 67.46
52 Week Low 16.53
Average Volume 467,547
200-Day Moving Average 40.67
50-Day Moving Average 46.47
20-Day Moving Average 43.75
10-Day Moving Average 42.76
Average True Range 2.75
ADX 21.45
+DI 14.98
-DI 28.14
Chandelier Exit (Long, 3 ATRs ) 39.09
Chandelier Exit (Short, 3 ATRs ) 45.73
Upper Bollinger Band 47.51
Lower Bollinger Band 39.99
Percent B (%b) 0.12
BandWidth 17.18
MACD Line -1.23
MACD Signal Line -1.03
MACD Histogram -0.201
Fundamentals Value
Market Cap 2.26 Billion
Num Shares 55.2 Million
EPS -1.85
Price-to-Earnings (P/E) Ratio -22.08
Price-to-Sales 0.00
Price-to-Book 7.11
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 44.14
Resistance 3 (R3) 44.17 43.14 43.60
Resistance 2 (R2) 43.14 42.32 43.12 43.42
Resistance 1 (R1) 42.02 41.81 41.51 41.99 43.24
Pivot Point 40.99 40.99 40.73 40.97 40.99
Support 1 (S1) 39.87 40.17 39.36 39.84 38.58
Support 2 (S2) 38.84 39.66 38.82 38.40
Support 3 (S3) 37.72 38.84 38.22
Support 4 (S4) 37.69